Portfolio Expansion: KNIPSA1100 receives MDR Certification

Expansion of the product portfolio

Joline continuously develops its product portfolio and drives innovation across various areas of medical technology – always with the goal of providing healthcare professionals worldwide with reliable solutions for modern patient care.

Various lengths available for different access points

With the introduction of the KNIPSA1100, Joline is expanding its portfolio of endomyocardial biopsy forceps. The new model features an insertion length of 109 cm and complements the established KNIPSA500. The extended length of the KNIPSA1100 offers clinicians additional application options and supports precise execution of endomyocardial biopsies. The KNIPSA500 is preferably intended for the introduction via the right internal jugular vein, while the KNIPSA1100 is intended for the introduction via one of the femoral veins.

The KNIPSA product family “Made in Germany” offers the following features:

  • Various lengths available for different access points

  • Sharp edges

  • Excellent maneuverability

  • Bowden cable is easy to move

  • Suitable for both ambulatory and stationary use

MDR Certification for KNIPSA500 and KNIPSA1100

An important milestone has now been achieved: both products have been certified under the European Medical Device Regulation (EU) 2017/745 (MDR). The KNIPSA500 and KNIPSA1100 meet all MDR requirements, ensuring that the products comply with the highest standards of patient safety, performance, and regulatory conformity. MDR certification provides assurance that clinical application is safeguarded not only technically but also from a regulatory perspective.

MDR certification also carries significant importance for international markets. It signals to clinics and healthcare institutions worldwide that the products have been tested and certified according to strict European standards.

Further information can be found on the product page.